Cargando…

Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition

Pancreatic cancer remains intractable owing to the lack of effective therapy for unresectable cases. Activating mutations of K-ras are frequently found in pancreatic cancers, but these have not yet been targeted by cancer therapies. The Keap1-Nrf2 system plays a crucial role in mediating the oxidati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamada, Shin, Matsumoto, Ryotaro, Tanaka, Yu, Taguchi, Keiko, Yamamoto, Masayuki, Masamune, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918355/
https://www.ncbi.nlm.nih.gov/pubmed/33672789
http://dx.doi.org/10.3390/ijms22041870

Ejemplares similares